Financial News

Financial Report: Sanofi

Pharmaceuticals sales up 3% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Sanofi 3Q Revenues: €9.1 billion (flat) 3Q Earnings: €2.9 billion (-1%) YTD Revenues: €26.4 billion (+6%) YTD Earnings: €7.7 billion (+7%) Comments: Pharmaceuticals sales were up 3% to €7.1 billion in the quarter. Sanofi Genzyme sales were up 14% at CER to €1.4 billion due to the strong U.S. launch of Dupixent and growth in Multiple Sclerosis. Lantus sales were €867 million, down 25%. Toujeo sales were up 9% to €179 million. Cerezyme sales were down 6% to €119 million. Myozyme sales were €1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters